With the expression level increasing, the poorer prognosis was observed (Fig. 1B), and the higher expression of METTL1 was observed in bladder cancer with metastasis group comparing to bladder cancer without metastasis group (P value: 2.022e-3) (Supplementary Fig. S1A). Here, METTL1 is linked to urinary bladder carcinoma.